---
title: "MBIO.US (MBIO.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MBIO.US/news.md"
symbol: "MBIO.US"
name: "MBIO.US"
parent: "https://longbridge.com/en/quote/MBIO.US.md"
datetime: "2026-03-13T20:56:54.613Z"
locales:
  - [en](https://longbridge.com/en/quote/MBIO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MBIO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MBIO.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/MBIO.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/MBIO.US/news.md)


# MBIO.US (MBIO.US) — Related News

### [10:41 ETBota uruchamia SAION AI - platformę fizycznej sztucznej inteligencji dedykowaną bioprodukcji](https://longbridge.com/en/news/278742287.md)
*2026-03-11T14:42:17.000Z*
> Bota has launched SAION AI, the first physical artificial intelligence platform dedicated to bioproduction. This compreh

### [Bota Launches SAION AI -- Physical AI Platform for Biomanufacturing](https://longbridge.com/en/news/278620983.md)
*2026-03-10T21:33:00.000Z*
> Bota has launched SAION AI, the first Physical AI platform for biomanufacturing, integrating cognition, orchestration, a

### [Ascribe Announces Collaboration with Corteva to Advance Seed Treatment Use for Phytalix® Biofungicide](https://longbridge.com/en/news/277943732.md)
*2026-03-05T13:08:08.000Z*
> In Ithaca, New York, Ascribe Bio and Corteva have revealed a partnership for research and development aiming to enhance 

### [Gordian Bio releases preprint on scalable in vivo screening platform for disease biology in South San Francisco.](https://longbridge.com/en/news/277787163.md)
*2026-03-04T13:11:53.000Z*
> A biotech company based in South San Francisco, California, Gordian Bio, has recently published a preprint showcasing th

### [Mursla Bio Accelerates US Commercial Deployment of EvoLiver Through ABHI Programme](https://longbridge.com/en/news/277747566.md)
*2026-03-04T08:31:54.000Z*
> Mursla Bio has been selected for the ABHI US Accelerator to enhance the commercial deployment of EvoLiver, its FDA-desig

### [Exploring Belite Bio's Earnings Expectations](https://longbridge.com/en/news/277224746.md)
*2026-02-27T16:00:51.000Z*
> Belite Bio (NASDAQ:BLTE) will report its quarterly earnings on March 2, 2026, with analysts estimating an EPS of $-0.55.

### [Consano Bio CEO to present at BIO Investment & Growth Summit on March 2-3, 2026 in Burlington, Massachusetts.](https://longbridge.com/en/news/276608751.md)
*2026-02-23T13:36:13.000Z*
> On February 23, 2026, Consano Bio, a biotechnology company based in Burlington, Massachusetts, shared news about their C

### [Nexeos Bio Gets FDA Clearance to Begin Phase II/III Trial of NTX-1024](https://longbridge.com/en/news/276358671.md)
*2026-02-19T16:45:02.000Z*
### [07:33 ETVie Ventures Names Jeff Bluestone, PhD, as Managing Director](https://longbridge.com/en/news/276332858.md)
*2026-02-19T12:33:56.000Z*
> Vie Ventures has appointed Dr. Jeff Bluestone as Managing Director. A renowned immunologist, Dr. Bluestone's expertise i